Please login to the form below
addiction
This page shows the latest addiction news and features for those working in and with pharma, biotech and healthcare.
US bankruptcy judge approves Purdue Pharma’s $6bn opioid settlement plan
The Sackler family will pay the amount over 18 years to victims of addiction and US states. ... The Sackler family, owners of Purdue Pharma, will pay between $5.5bn and $6bn over the course of 18 years to victims of addiction and US states for their role
Latest news
-
US President Biden nominates Robert Califf as FDA commissioner
He said: “His nomination is an insult to the many families and individuals who have had their lives changed forever as a result of addiction.
-
J&J, distributors reach $26bn settlement to address the opioid crisis in the US
In August 2019, J&J was ordered to pay $572m after judge Thad Balkman concluded it was guilty of misleading marketing strategies that helped to cause a surge in opioid addiction
-
Purdue to pay over $8bn to settle opioid-related criminal claims
The new company will provide opioid overdose reversal medication, as well as addiction treatment medications at no or low cost. ... The abuse and diversion of prescription opioids has contributed to a national tragedy of addiction and deaths, in addition
-
US states claim Purdue Pharma owes $2.2 trillion over opioid crisis
well as millions of doses of lifesaving opioid addiction treatment and overdose reversal medicines,” Purdue said in a statement. ... The millions of families that have suffered as the result of addiction, ailments and death can never be repaid for
-
Mallinckrodt reaches tentative $1.6bn opioid settlement
The money will be used to underwrite the costs of opioid addiction treatments and related efforts in the US, a public health crisis which claimed almost 218, 000 lives in the ... As part of an agreement made with a number of plaintiffs, Purdue
More from news
Approximately 6 fully matching, plus 82 partially matching documents found.
Latest Intelligence
-
The future of work has been just around the corner for some time...
Turned engagement into an addiction: building on strong psychological safety and trust, we communicated authentically, stayed together virtually, encouraged humanised check-ins and had fun together.
-
The transatlantic opioid crisis
Synthetic opioids are now widely regarded to be the root cause of an epidemic of painkiller addiction in the USA. ... These prescription and addiction rates far outstrip those per capita in London and the Home Counties.
-
As the opioid crisis grabs the headlines, the search for safe treatments continues
Tackling the global crisis of addiction is not a labour for the faint-hearted. ... be fully dedicated to helping patients, doctors and communities dealing with opioid addiction.’.
-
Drug launches to watch in 2019
11. Buvidal – an advance in opioid dependence treatment. Opioid addiction has surged in the US since the 1990s, when prescription drugs such as OxyContin and Vicodin became a common remedy for ... The US market for the treatment of opioid addiction is
-
Revenue down the back of the beanbag
It’s become a boardroom agenda item; one where someone typically feels obliged to comment on his or her nephew’s smartphone addiction and low attention span.
More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.
Latest appointments
-
New faces at Merus, Rubius Therapeutics and Titan Pharmaceuticals
DeVarney joined Titan over ten years ago, and has lead the development of its opioid addiction treatment Probuphine.
-
New faces at Lucid, 90Ten and Page & Page
Robinson has over 4 years’ experience in editorial and medical writing, with specialities in addiction medication and cystic fibrosis.
-
BMS appoints new commercial leader, Davies joins Eisai and more
There, she will be responsible for leading its generics business, including retail sales, addiction therapy sales and branded sales teams.
-
Hanover appoints new associate director
Previously he spent five years in-house with Schering-Plough and MSD, working on brand communications across immunology, CVD, respiratory, virology and addiction portfolios.
More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
Hepatitis (C)an’t wait: taking a de-centralized approach to cure the epidemic
Successful strategies for engaging hard-to-reach patients. Why treating patients in active addiction is crucial for tackling the disease.
-
Employee wellbeing in creative agencies: three tips to get you started
Research suggests that living in this state creates chronic stress contributing to high blood pressure, formation of artery-clogging deposits and brain changes that may contribute to anxiety, depression and addiction.
-
Supporting Mental Health During a Global Pandemic
Sam Duboc, Chair &CEO of MindBeacon, explores virtual care and telehealth for treating depression, anxiety, addiction, and other conditions; mental health issues brought on by COVID-19; and how to virtually
-
Can wearables really transform healthcare?
As we become more reliant on our devices and our addiction to being connected 24/7, healthcare problems related to poor posture have emerged.
-
Lucid kick-starts 2019 with spellbinding new additions to its writing and account teams
Sarah has over 4 years’ experience in editorial and medical writing, with specialities in addiction medication and cystic fibrosis.
More from PMHub
Approximately 4 fully matching, plus 10 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- MSD and AstraZeneca announce phase 3 results for prostate cancer therapy
- Novartis publishes final positive phase 3 results of Zolgensma in Nature Medicine
- Biogen and Happify Health team up to create digital platform for MS patients
- Myovant Sciences and Pfizer publish phase 3 results for endometriosis therapy
- Happify Health and Almirall launch Claro to support psoriasis patients
- College of Medicine launches Beyond Pills campaign to tackle overprescribing in UK health system
- VMLY&R wins two Grand Prix awards at Cannes Lions International Festival of Creativity 2022
- Novartis and Precision BioSciences announce in vivo gene editing collaboration
- Enanta takes legal action against Pfizer over Paxlovid patent infringement
- Sanofi and GSK report positive data for COVID-19 Beta vaccine
- Pfizer donates $5m in Russian profits to humanitarian causes amid war in Ukraine
- Delivering content to fuel omnichannel engagement
PMHub
Health Unlimited
Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...
Latest intelligence
- A creative awakening – how pharma is bringing innovation to the patient journey
- By Danny Buckland...
- MEDSCAPE EDUCATION: The Human Story in Virtual Patient Simulation
- ...
- Windrush Day
- Innnovative Trials' Equality & Diversity committee raises awareness around Windrush Day and the Windrush generation...
